Abstract
Glycyrrhiza may be appropriate as an adjunctive therapy for a variety of disorders involving mild adrenal insufficiency, low aldosterone output, or hyperkalemia due to effects on 11-β-HSD enzymes, direct effects at mineralocorticoid receptors, and downstream effects on aldosterone as well as fluid and electrolyte balance. Glycyrrhiza has also been shown to help correct hyperkalemia that may result from spirolactone therapy in PCOS. Patients with orthostatic hypotension may respond to Glycyrrhiza therapy due to its ability to improve blood volume and potassium levels and reduce activation of baroreceptors.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
